AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 191 filers reported holding AMAG PHARMACEUTICALS INC in Q3 2017. The put-call ratio across all filers is 3.11 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2019 | $967,000 | +4.3% | 96,842 | +34.5% | 0.06% | +9.6% |
Q1 2019 | $927,000 | -15.3% | 72,000 | 0.0% | 0.05% | -14.8% |
Q4 2018 | $1,094,000 | -79.8% | 72,000 | -75.5% | 0.06% | -65.9% |
Q3 2017 | $5,413,000 | +8.5% | 293,400 | +133.7% | 0.18% | +59.8% |
Q3 2015 | $4,988,000 | +1775.2% | 125,550 | +878.4% | 0.11% | +1500.0% |
Q2 2014 | $266,000 | -73.3% | 12,832 | -75.1% | 0.01% | -70.8% |
Q1 2014 | $996,000 | – | 51,450 | – | 0.02% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Broadfin Capital, LLC | 3,921,550 | $81,254,000 | 4.00% |
Palo Alto Investors LP | 1,614,536 | $33,453,000 | 2.49% |
Ghost Tree Capital, LLC | 100,000 | $2,072,000 | 1.46% |
March Altus Capital Management LP | 146,418 | $3,034,000 | 1.11% |
IRONWOOD INVESTMENT MANAGEMENT LLC | 296,458 | $6,143,000 | 0.98% |
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 999,339 | $20,706,000 | 0.83% |
Visium Asset Management, LP | 2,070,870 | $42,908,000 | 0.67% |
AlphaOne Investment Services, LLC | 97,448 | $2,019,000 | 0.54% |
CONTINENTAL ADVISORS LLC | 57,438 | $1,190,000 | 0.28% |
Tamarack Capital Management, LLC | 64,080 | $1,222,000 | 0.25% |